Oncology News and Research

RSS
Radiation boost provides added benefit to DCIS patients following breast-conserving surgery and WBRT

Radiation boost provides added benefit to DCIS patients following breast-conserving surgery and WBRT

Cryoablation appears to be viable option for early stage breast cancer treatment

Cryoablation appears to be viable option for early stage breast cancer treatment

Combination of different drugs could improve effect of immunotherapy on skin cancer

Combination of different drugs could improve effect of immunotherapy on skin cancer

Expectations of cancer patients may not match with actual results in phase I studies

Expectations of cancer patients may not match with actual results in phase I studies

Intermediate risk prostate cancer patients can achieve survival benefit with brachytherapy alone

Intermediate risk prostate cancer patients can achieve survival benefit with brachytherapy alone

Association for Molecular Pathology announces winners of 2016 awards

Association for Molecular Pathology announces winners of 2016 awards

Increasing adoption of SBRT improves survival rates for older patients with early stage lung cancer

Increasing adoption of SBRT improves survival rates for older patients with early stage lung cancer

Adolescent girls with family breast cancer history do not experience negative psychological effects

Adolescent girls with family breast cancer history do not experience negative psychological effects

Cross-disciplinary concepts may lead to effective, personalised cancer treatments

Cross-disciplinary concepts may lead to effective, personalised cancer treatments

IMRT reduces risk of side effects, improves quality of life for endometrial and cervical cancer patients

IMRT reduces risk of side effects, improves quality of life for endometrial and cervical cancer patients

New NCCN Guidelines outline diagnosis, treatment strategies for myeloproliferative neoplasms

New NCCN Guidelines outline diagnosis, treatment strategies for myeloproliferative neoplasms

Study reveals radiosurgery as viable treatment option for patients with resected brain metastases

Study reveals radiosurgery as viable treatment option for patients with resected brain metastases

Hypofractionated RT can reduce treatment time by half in stage II and III NSCLC patients

Hypofractionated RT can reduce treatment time by half in stage II and III NSCLC patients

SRS reduces likelihood of local recurrence of brain metastases in cancer patients

SRS reduces likelihood of local recurrence of brain metastases in cancer patients

Researchers identify, validate three distinct molecular subtypes of prostate cancer

Researchers identify, validate three distinct molecular subtypes of prostate cancer

Increased use of SBRT linked to improved survival outcomes of NSCLC patients

Increased use of SBRT linked to improved survival outcomes of NSCLC patients

Equicare Health exhibits oncology patient engagement software at ASTRO 2016

Equicare Health exhibits oncology patient engagement software at ASTRO 2016

Qfix launches new Symphony Patient Transport System to safely increase workflow efficiencies

Qfix launches new Symphony Patient Transport System to safely increase workflow efficiencies

Yale researchers compare efficacy of four PD-L1 assay tests

Yale researchers compare efficacy of four PD-L1 assay tests

Investigators provide data on status of psychosomatic medicine in Germany

Investigators provide data on status of psychosomatic medicine in Germany

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.